Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis

被引:58
作者
Murphy, Sarah E. [1 ]
Bicanic, Tihana [1 ,2 ]
机构
[1] St Georges Univ London, Inst Infect & Immun, London, England
[2] St Georges Univ Hosp Natl Hlth Serv NHS Fdn Trust, Clin Acad Grp Infect & Immun, London, England
关键词
Candida; invasive candidiasis; candidaemia; antifungal resistance; antifungal drugs; drug therapy; drug resistance; antimicrobial resistance; BROAD-SPECTRUM ANTIFUNGAL; GLUCAN SYNTHASE INHIBITOR; LONG-ACTING ECHINOCANDIN; IN-VITRO ACTIVITY; INFECTIOUS-DISEASES SOCIETY; CELECOXIB DERIVATIVE AR-12; HIGHLY POTENT INHIBITOR; AMPHOTERICIN-B; MURINE MODEL; TREHALOSE-6-PHOSPHATE PHOSPHATASE;
D O I
10.3389/fcimb.2021.759408
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Candida species are the leading cause of invasive fungal infections worldwide and are associated with acute mortality rates of ~50%. Mortality rates are further augmented in the context of host immunosuppression and infection with drug-resistant Candida species. In this review, we outline antifungal drugs already in clinical use for invasive candidiasis and candidaemia, their targets and mechanisms of resistance in clinically relevant Candida species, encompassing not only classical resistance, but also heteroresistance and tolerance. We describe novel antifungal agents and targets in pre-clinical and clinical development, including their spectrum of activity, antifungal target, clinical trial data and potential in treatment of drug-resistant Candida. Lastly, we discuss the use of combination therapy between conventional and repurposed agents as a potential strategy to combat the threat of emerging resistance in Candida.
引用
收藏
页数:22
相关论文
共 235 条
[61]   EVOLVING ROLE OF FLUCYTOSINE IN IMMUNOCOMPROMISED PATIENTS - NEW INSIGHTS INTO SAFETY, PHARMACOKINETICS, AND ANTIFUNGAL THERAPY [J].
FRANCIS, P ;
WALSH, TJ .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (06) :1003-1018
[62]   Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint [J].
Garcia-Effron, Guillermo ;
Lee, Samuel ;
Park, Steven ;
Cleary, John D. ;
Perlin, David S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) :3690-3699
[63]   Multifactorial Role of Mitochondria in Echinocandin Tolerance Revealed by Transcriptome Analysis of Drug-Tolerant Cells [J].
Garcia-Rubio, Rocio ;
Jimenez-Ortigosa, Cristina ;
DeGregorio, Lucius ;
Quinteros, Christopher ;
Shor, Erika ;
Perlin, David S. .
MBIO, 2021, 12 (04)
[64]   Critical Assessment of Cell Wall Integrity Factors Contributing to in vivo Echinocandin Tolerance and Resistance in Candida glabrata [J].
Garcia-Rubio, Rocio ;
Hernandez, Rosa Y. ;
Clear, Alissa ;
Healey, Kelley R. ;
Shor, Erika ;
Perlin, David S. .
FRONTIERS IN MICROBIOLOGY, 2021, 12
[65]   Efficacy of the Clinical Agent VT-1161 against Fluconazole-Sensitive and -Resistant Candida albicans in a Murine Model of Vaginal Candidiasis [J].
Garvey, E. P. ;
Hoekstra, W. J. ;
Schotzinger, R. J. ;
Sobel, J. D. ;
Lilly, E. A. ;
Fidel, P. L., Jr. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (09) :5567-5573
[66]   Aspiring Antifungals: Review of Current Antifungal Pipeline Developments [J].
Gintjee, Thomas J. ;
Donnelley, Monica A. ;
Thompson, George R., III .
JOURNAL OF FUNGI, 2020, 6 (01)
[67]   Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets [J].
Gong, Ying ;
Li, Tao ;
Yu, Cuixiang ;
Sun, Shujuan .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
[68]   Deacetylase enzymes: biological functions and the use of small-molecule inhibitors [J].
Grozinger, CM ;
Schreiber, SL .
CHEMISTRY & BIOLOGY, 2002, 9 (01) :3-16
[69]  
Hager CL, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02319-17, 10.1128/aac.02319-17]
[70]   Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity [J].
Hamill, Richard J. .
DRUGS, 2013, 73 (09) :919-934